Project Details
Description
A Global Phase 2 Study to Evaluate the Efficacy and Safety of ARX788 for Selected HER2-mutated or HER2-amplified/over-expressed Solid Tumors
| Status | Active |
|---|---|
| Effective start/end date | 3/4/22 → 3/31/27 |
Funding
- AMBRX, INC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.